Sunshine Biopharma share price logo

Sunshine Biopharma

NASDAQ: SBFM

$0.14

-0.03

(-18.32%)

Live

as on

Sunshine Biopharma Stock Performance

as on October 24, 2026 at 6:28 am IST

  • Day's Low

    Day's High

    $0.13
    $0.17
    downward going graph

    4.69%

    Downside

    24.63%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.16
    $23.20
    downward going graph

    -15.65%

    Downside

    16908.80%

    Upside

    downward going graph

Sunshine Biopharma share price movements today

Previous Close
$0.17
Open
$0.17
Volume
1.7M
Market Cap
$3.2M
Day's Low - High
$0.13 - $0.17
52 Week Low - High
$0.16 - $23.20

Sunshine Biopharma Historical Returns

1 Month Return
-80.93 %
3 Month Return
-90.23 %
1 Year Return
-99.1 %
3 Year Return
-100 %
5 Year Return
0 %

Sunshine Biopharma Stock Fundamentals & Key Indicators

Check Sunshine Biopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.2M

EPS (TTM)

-10.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.02

Industry PE ratio

-9.79

PEG Ratio

-0.00

EBITDA

-5.3M

Revenue (TTM)

35.3M

Profit Margin

29.80%

Return On Equity TTM

-24.23%

Sunshine Biopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sunshine Biopharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Sunshine Biopharma image
Sunshine Biopharma
Buy$3.2MNA-0.0229.80%0.00%
Sandoz Group Ltd Sponsored ADR image
Sandoz Group Ltd Sponsored ADR
Buy$41.2BNA63.9047.54%1.08%
United Therapeutics image
United Therapeutics
StrongBuy$24.2B206.16%18.6486.14%0.00%
Viatris image
Viatris
Buy$21.4B32.57%-51.2534.83%2.60%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
Buy$44.3BNA20.5465.57%1.98%
See all

Stock Returns calculator for Sunshine Biopharma Stock including INR - Dollar returns

The Sunshine Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Sunshine Biopharma investment value today

Current value as on today

₹797

Returns

-₹99,203

(-99.2%)

Returns from Sunshine Biopharma Stock

-₹99,263 (-99.26%)

Dollar Impact

₹60 (+0.06%)

Analyst Recommendation on Sunshine Biopharma Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Sunshine Biopharma. Average target price of $56

Sunshine Biopharma Share Price Target

Get share price movements and forecasts by analysts on Sunshine Biopharma.

What analysts predicted

99.76%UPSIDE

Target Price

$56

Current Price

$0.1364

Analyzed by

7 Analysts

Target

$56.00

Sunshine Biopharma target price $56, a slight upside of 99.76% compared to current price of $0.1364. According to 7 analysts rating.

Indian Investors' Interest in Sunshine Biopharma Stock

Investment in Sunshine Biopharma Shares on INDmoney has grown by 2141.17% in the last 30 days, indicating increased investment activity.

Time period: to

Change:2141.17% versus previous 30 day period

Search interest for Sunshine Biopharma Stock has increased by 989% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:989% versus previous 30 day period

Sunshine Biopharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
7
9
8
9
8
9
9
8
8
9
Gross Profit
2
2
2
3
2
3
3
2
2
2
Operating Income
-1
-1
-1
-2
-1
0
0
-1
-1
-1
EBITDA
-1
0
0
-2
-1
-1
0
-1
-1
-1
Interest Expense
0
0
-
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
0
0
-2
-1
-1
-1
-1
-1
-1
Income Tax Expense
0
0
0
0
0
0
0
0
-
-
Net Income
-1
0
-1
-2
-1
-1
0
-2
-1
-1
Net Profit Margin
30.66%
24.78%
33.98%
32.24%
30.67%
36.37%
32.64%
34.16%
26.01%
26.20%

Sunshine Biopharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Mar 2024
Dec 2024
Dec 2025
Total Revenue
-
0
0
0
0
4
24
34
36
Gross Profit
0
0
0
0
0
1
8
10
11
Operating Income
0
-1
0
0
-2
-8
-4
-5
-4
EBITDA
0
-1
0
-2
-12
-26
-3
-5
-5
Interest Expense
0
0
0
0
0
0
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-2
-1
-2
-12
-26
-4
-5
-5
Income Tax Expense
0
-
-
-
-
0
0
0
0
Net Income
-1
-2
-1
-2
-12
-26
-4
-5
-5
Net Profit Margin
0.00%
12.55%
47.68%
63.80%
48.42%
39.05%
34.61%
30.60%
32.84%

Sunshine Biopharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
0
-1
-2
-1
-1
0
-2
-1
-1
Operating Cash Flow
-3
-4
-1
-3
-1
-1
0
-1
-2
0
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
5
0
1
2
0
3
0
0
-
7
Change in Cash
1
-5
0
-2
-1
2
0
0
-2
6

Sunshine Biopharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Mar 2024
Dec 2024
Dec 2025
Net Income
-1
-2
-1
-2
-12
-26
-4
-5
-5
Operating Cash Flow
0
0
0
0
-1
-5
-8
-12
-5
Investing Cash Flow
0
0
0
0
-
-14
0
-2
0
Financing Cash Flow
0
0
0
1
2
39
3
9
4
Change in Cash
0
0
0
0
1
19
-5
-6
0

Global Institutional Holdings in Sunshine Biopharma

Check out the Institutions with significant holdings in Sunshine Biopharma.

Funds
Holdings
Citadel Advisors Llc
0.19%
Commonwealth Equity Services, LLC
0.06%
Caitong International Asset Management Co., Limited.
0.00%
UBS Group AG
0.00%
Jane Street Group LLC
3.05%
See all

Sunshine Biopharma News & Key Events

  • img

    Today's Timeline - 09 October

    Fri, 08:47 PM

    -

    Sunshine Biopharma closes public offering, raising approximately $6 million for corporate purposes and drug development.

Insights on Sunshine Biopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 8.08M → 9.26M (in $), with an average increase of 12.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 79.2% return, outperforming this stock by 178.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 107.2% return, outperforming this stock by 207.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -1.24M → -1.56M (in $), with an average decrease of 25.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SBFM stock has moved down by -24.7%

About Sunshine Biopharma

Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, and liver cancers. Notably, Adva-27a also demonstrates efficacy against multidrug-resistant cancer cells, encompassing pancreatic, breast, small-cell lung, and uterine sarcoma cells. The company is also progressing SBFM-PL4, a compound under development as an anti-coronavirus treatment. In addition to its drug development, Sunshine Biopharma markets a range of nutritional products, such as the Essential 9 tablet and the Essential Calcium-Vitamin D supplement, alongside other scientifically formulated dietary aids. A collaboration with the University of Georgia supports the ongoing advancement of SBFM-PL4 as an anti-coronavirus agent. The firm's headquarters are situated in Pointe-Claire, Canada.
OrganisationSunshine Biopharma
Headquarters333 Las Olas Way, Fort Lauderdale, FL, 33301, US
IndustryDrug Manufacturers - Specialty & Generic
CEOSteve N. Slilaty

Key Management of Sunshine Biopharma

Name

Title

Mr. Malek Chamoun

Chief Development Officer

Mr. Robert G. Ferreira

President of Sunshine Bio Investments Inc

Dr. Steve N. Slilaty Ph.D.

Chairman, President & CEO

Mr. Camille Sebaaly

CFO, Secretary & Director

Mr. Michel Roy

Chief Commercial Officer

FAQs

What is Sunshine Biopharma share price today?

Sunshine Biopharma share price today is $0.14 as on . Sunshine Biopharma share today touched a day high of $0.17 and a low of $0.13.

What is the 52 week high and 52 week low for Sunshine Biopharma share?

Sunshine Biopharma share touched a 52 week high of $23.20 on and a 52 week low of $0.16 on . Sunshine Biopharma stock price today i.e. is trending at $0.14,which is 99.41% down from its 52 week high and -13.53% up from its 52 week low.

What is Sunshine Biopharma's market capitalisation today?

Sunshine Biopharma market capitalisation is $0.00T as on .

How to invest in Sunshine Biopharma Stock (SBFM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sunshine Biopharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Sunshine Biopharma Stock (SBFM) from India?

Indian investors can start investing in Sunshine Biopharma (SBFM) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Sunshine Biopharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Sunshine Biopharma share’s latest price of $0.14 as on October 24, 2026 at 12:58 am IST, you will get 73.3138 shares of Sunshine Biopharma. Learn more about fractional shares .